Yeganeh Reuven 4
4 · BiomX Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
BiomX (PHGE) 10% Owner Yeganeh Reuven Sells Shares
What Happened
Yeganeh Reuven, a 10% owner of BiomX, converted Series Y convertible preferred shares into 670,000 shares of common stock (300,000 on 2026-03-11 and 370,000 on 2026-03-13) at a $2.00 conversion price (total cash cost $1.34M). Reuven then sold those 670,000 shares in private transactions at $5.00 per share (sales on 2026-03-12 and 2026-03-13) for total proceeds of $3.35M. The filing also reports two very small derivative-conversion line items (600 and 740 shares) recorded at $0.00 with no cash amount.
Key Details
- Transaction dates and prices:
- Conversions: 300,000 shares @ $2.00 (3/11) and 370,000 shares @ $2.00 (3/13) — total acquired 670,000 shares, $1,340,000 cost (per F1).
- Sales: 300,000 shares (3/12) and 370,000 shares (3/13) sold in private transactions @ $5.00 — total proceeds $3,350,000 (per F3).
- Small derivative entries: 600 shares (3/12) and 740 shares (3/13) recorded at $0.00 (no cash).
- Ownership after transactions: not specified in the provided filing details.
- Footnotes:
- F1: Conversions were from Series Y Convertible Preferred into common stock at $2.00/share.
- F2: Reported securities are directly owned by Pyu Pyu Capital, LLC; Reuven is sole member and disclaims beneficial ownership except for pecuniary interest.
- F3: Sales were private transactions at $5.00/share.
- Filing timeliness: Form 4 filed 2026-03-13 covering transactions 2026-03-11 to 2026-03-13; filing appears timely.
Context
These transactions are conversions of preferred stock into common shares followed by private sales (not open-market trades). Conversions at a fixed conversion price are different from open-market purchases; here Reuven monetized converted shares via private sales. As a reported 10% owner (through an LLC), this is institutional/owner-level activity rather than an executive payroll sale—useful to note for investors tracking insider sentiment but not a direct indicator of company operational decisions.
Insider Transaction Report
- Conversion
Common Stock, $0.0001 par value per share
[F1][F2]2026-03-11$2.00/sh+300,000$600,000→ 30,000 total(indirect: By LLC) - Sale
Common Stock, $0.0001 par value per share
[F3][F2]2026-03-12$5.00/sh−300,000$1,500,000→ 0 total(indirect: By LLC) - Conversion
Common Stock, $0.0001 par value per share
[F1][F2]2026-03-13$2.00/sh+370,000$740,000→ 370,000 total(indirect: By LLC) - Sale
Common Stock, $0.0001 par value per share
[F3][F2]2026-03-13$5.00/sh−370,000$1,850,000→ 0 total(indirect: By LLC) - Conversion
Series Y Convertible Preferred Stock
[F1][F2]2026-03-12−600→ 2,700 total(indirect: By LLC)Exercise: $2.00From: 2026-01-13Exp: 2027-01-13→ Common Stock (300,000 underlying) - Conversion
Series Y Convertible Preferred Stock
[F1][F2]2026-03-13−740→ 1,960 total(indirect: By LLC)Exercise: $2.00From: 2026-01-13Exp: 2027-01-13→ Common Stock (370,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share.
- [F2]The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]The shares of Common Stock were sold in private transactions at a price of $5.00 per share.